Clinical Trial Update: Pulmonary Fibrosis During Severe COVID-19 Pneumonia

View source ↗

Summary

This clinical trial update reports research on pulmonary fibrosis in patients with severe COVID-19 pneumonia (SARS-CoV-2–related ARDS), with the study currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Fibrosis
• Respiratory Distress Syndrome

Snippet

Sponsor: Hôpital Européen Marseille | Conditions: Severe Acute Respiratory Syndrome Coronavirus 2, Acute Respiratory Distress Syndrome | Status: ACTIVE_NOT_RECRUITING